Clinical Validation of Myriad Genetics’ Ultra-Sensitive pan-cancer WGS-based Precise MRD assay

• Understand how ultra-sensitive, tumor-informed MRD testing is being applied across clinical and development settings
• Walk away with a clear view of where ultra-sensitive MRD testing delivers value today and how to apply it across your own programs

Speakers:

Dale Muzzey

Chief Scientific Officer

Myriad Genetics